Want to join the conversation?
For 3Q17, $ADSK expects revenue of $470-485MM and GAAP loss per share of $0.74-0.81. For FY17, revenue is expected to be $2.00-2.05Bil and GAAP loss per share is expected to be $2.74-2.97. Excluding the impact of foreign currency exchange rates and hedge gains/losses, revenue guidance would be $2.04-2.09Bil for FY17.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?